Personal information

Websites & social links

LinkedIn

Countries

Iran

Activities

Collapse all

Employment (4)

Mofid Pharma: Karaj, Hashtgerd, IR

2020-12 to present | Quality Assurance Manager (Quality Assurance)
Employment
Source: Self-asserted source
FARNAZ SHOKRANEH

Modava Pharmaceutical Co: Karaj, Hashtgerd, IR

2018-07 to 2020-07 | Quality Assurance Manager & responsible pharmacist (Quality Assurance &Regulatory)
Employment
Source: Self-asserted source
FARNAZ SHOKRANEH

Modava Pharmaceutical Co : Karaj, Hashtgerd, IR

2017-06 to 2018-07 | Quality Assurance Manager (Quality Assurance)
Employment
Source: Self-asserted source
FARNAZ SHOKRANEH

ATI Pharmed Pharmaceutical Co : Karaj, IR

2013-04 to 2017-06 | Quality Control Manager (Quality Contro)
Employment
Source: Self-asserted source
FARNAZ SHOKRANEH

Education and qualifications (20)

Freie Universität Berlin: Berlin, DE

2021 to present | Quality Management
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Surena Akademi: Tehran, IR

2021 to 2021 (Biotechnology School)
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2021 to 2021 | Statistical training course with pharmaceutical approach
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Modava Pharmaceutical company: Tehran, IR

2018 to 2018 | Quality events management
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Chemo (Spain): Leon, ES

2016 to 2016 | Quality Control
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2015 to 2015 | Preparation & Validation of working Standard in Quality Control Laboratories
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2015 to 2015 | Inspection of Microbiological Laboratories
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2015 to 2015 | Quality Assurance in Quality Control Laboratories
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2015 to 2015 | API & Finished Product Stability Studies according to ICH Q1
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2014 to 2014 | Quality Risk Management
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2014 to 2014 | Establishment of Quality Assurance System
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2014 to 2014 | Sampling according to Mil 105E & ISO 2859
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2014 to 2014 | Good Practice for Quality Laboratories
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2014 to 2014 | In Process Quality Controls IN Pharmaceutical Industry
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

STRAGEN PHARMA: Tehran, IR

2013 to 2013 | Qualification and process validation
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2013 to 2013 | GC and Residual Solvents in APIs
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2013 to 2013 | Nine principles of GMP-PIC/S
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Ofogh Pharmed Institute: Tehran, IR

2013 to 2013 | Good manufacturing practice (GMP) Inspection
Qualification
Source: Self-asserted source
FARNAZ SHOKRANEH

Islamic Azad University Pharmaceutical Sciences Branch: Tehran, Tehran, IR

2007 to 2012 | Pharm.D (Pharmaceutical Sciences)
Education
Source: Self-asserted source
FARNAZ SHOKRANEH

Hoda High school: Tehran, Tehran, IR

2002 to 2005 | Diploma (Natural Sciences )
Education
Source: Self-asserted source
FARNAZ SHOKRANEH

Professional activities (2)

Iranian Medical Council: Tehran, IR

2013 to present
Membership
Source: Self-asserted source
FARNAZ SHOKRANEH

Iranian Pharmacists Association: Tehran, MB, IR

2011 to present
Membership
Source: Self-asserted source
FARNAZ SHOKRANEH

Funding (1)

INSIDE7

2022 to 2023 | Grant
EDUFI (Helsinki, FI)
Source: Self-asserted source
FARNAZ SHOKRANEH

Works (7)

Automated extrusion-based dispensing: Personalized dosing and quality control of clopidogrel tablets for pediatric care

European Journal of Pharmaceutical Sciences
2025-01 | Journal article
DOI: 10.1016/j.ejps.2024.106967
Contributors: Farnaz Shokraneh; Anne M. Filppula; Aleksi Tornio; Jaan Aruväli; Urve Paaver; Niklas Sandler Topelius
Source: check_circle
Crossref

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Pharmaceutics
2024-05-17 | Journal article
DOI: 10.3390/pharmaceutics16050678
Contributors: Niklas Sandler Topelius; Farnaz Shokraneh; Mahsa Bahman; Julius Lahtinen; Niko Hassinen; Sari Airaksinen; Soumya Verma; Ludmila Hrizanovska; Jana Lass; Urve Paaver et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Iranian Journal of Pharmaceutical Research
2014-12 | Journal article
Source: Self-asserted source
FARNAZ SHOKRANEH

Comparative studies of cytotoxic manufacturing practices in specialized Cancer Centers against international guidelines (ASHP, OSHA, HSE-UK

FIP Congress
2012 | Conference poster
Source: Self-asserted source
FARNAZ SHOKRANEH

Development and validation of high-performance liquid chromatography for determination of Nystatin in pharmaceutical formulations

Research in Pharmaceutical science
2012 | Conference poster
Source: Self-asserted source
FARNAZ SHOKRANEH

A new HPLC method for determination of losartan in human plasma and its application in bioequivalence studies

Oriental Journal of Chemistry
2012-03 | Journal article
Source: Self-asserted source
FARNAZ SHOKRANEH

Risks to health professionals from hazardous drugs in Iran: a pilot study of understanding of healthcare team to occupational exposure to cytotoxics

EXCLI Journal
2005-05 | Journal article
Source: Self-asserted source
FARNAZ SHOKRANEH
How many people are using ORCID?